Endotrain Digital Endocrinology Training Network to combat adrenal diseases
- Coordinator
- Universitetet I Bergen, Norway
- Runs
- 1 January 2026 to 31 December 2029
- Status
- Running
- EU funding
- €4.8m
- Total cost
- —
- Partners
- 22 organisations in 10 countries
- Type
- Marie Skłodowska-Curie Action
- Grant agreement
- 101227148
What the project is doing
In the project's own words, from its summary on CORDIS.
Digital endocrine medicine is revolutionizing healthcare by integrating technology, data, and personalized treatment, enabling more precise, efficient, and accessible care that disrupts traditional medical models. Advancing digital endocrine medicine to the next level of knowledge and translational value demands an ‘integrative’ approach that departs from the conventional ‘sum of monothematic experts’ towards the ‘merging of multiple themes in one expert’.
In this fast developing field, interdisciplinary experts can better communicate across topics as dispersed as clinical medicine, data science (incl. machine learning and artificial intelligence), mathematics, engineering, biochemistry, biotechnology, ethics, law, while adapting academic findings to real word needs. ENDOTRAIN is poised to fill in the gap of interdisciplinary experts needed to advance digital endocrine medicine research and clinical application.
This doctoral network joins leading researchers and entrepreneurs from 8 countries to train 15 Doctoral Candidates (DCs), along with 4 DCs funded by Switzerland (SDCs), across different disciplines and sectors. Exceptionally trained in digital endocrine medicine, these versatile DCs will be prepared to face broader challenges beyond endocrinology and become the next generation of clinicians, scientists, and innovators, equipped to enhance Europe’s capacity to navigate the rapidly evolving landscape of digital medicine.
Topics
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Universitetet I Bergen | Bergen | Norway | Coordinator |
| 28digital | Bruxelles / Brussel | Belgium | Associatedpartner |
| Eidgenoessische Technische Hochschule Zuerich | Zuerich | Switzerland | Associatedpartner |
| Leitwert GmbH | Winterthur | Switzerland | Associatedpartner |
| Universitat Zurich | Zurich | Switzerland | Associatedpartner |
| Ludwig-Maximilians-Universitaet Muenchen | Planegg | Germany | Participant |
| Universitaet Ulm | Ulm | Germany | Participant |
| Ethniko Kai Kapodistriako Panepistimio Athinon | Athina | Greece | Associatedpartner |
| Perifereiako Geniko Nosokomeio Athinon Evaggelismos | Athina | Greece | Participant |
| Adhera Health Slu | Sevilla | Spain | Participant |
| Universite Cote D'azur | Nice | France | Participant |
| Universita Degli Studi Di Roma La Sapienza | Roma | Italy | Participant |
| Preforma AS | Bergen | Norway | Associatedpartner |
| Karolinska Institutet | Stockholm | Sweden | Participant |
| Rarity Bioscience AB | Uppsala | Sweden | Associatedpartner |
| Designworks Windsor Ltd | Windsor | United Kingdom | Associatedpartner |
| Dynamic Therapeutics Ltd | Bristol | United Kingdom | Associatedpartner |
| Imperial College of Science Technology and Medicine | London | United Kingdom | Participant |
| The University of Birmingham | Birmingham | United Kingdom | Participant |
| The University of Manchester | Manchester | United Kingdom | Participant |
| The University of Reading | Reading | United Kingdom | Participant |
| University of Bristol | Bristol | United Kingdom | Participant |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI